A Phase I, Open-Label, Single-Sequence Drug-Drug Interaction Trial in Subjects on Stable Methadone Maintenance Therapy, to Investigate the Potential Interaction Between TMC278 25 mg q.d. and Methadone, at Steady-State.
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2013
At a glance
- Drugs Rilpivirine (Primary) ; Methadone
- Indications Heroin abuse; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 15 Jul 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.